| E. COLI | Monitoring | 0 | N/A | Jun 4, 2025 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 4, 2025 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 8, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 8, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 8, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 8, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 23, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 23, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 23, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 23, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 23, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 23, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 2, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 2, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 2, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 2, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Health-Based | N/A | 0.007 | Jun 30, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Health-Based | N/A | 0.007 | Jun 30, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Health-Based | N/A | 0.007 | Jun 30, 2024 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| E. COLI | Monitoring | 0 | N/A | Jan 4, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jan 4, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jan 4, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jan 4, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 8, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 8, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 8, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 8, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 8, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 8, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 8, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 8, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 235 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 235 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 235 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 235 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 298 | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 298 | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 298 | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 298 | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 7, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Sep 15, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 15, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 15, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 15, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |